Rapid Point-of-Care Quantification of Urinary Tract Infection Biomarker Xanthine Oxidase
ACS Omega · 10.11.2026 · 11 (44) · 69381-69388
DOI: 10.1021/acsomega.6c10153 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Omega, online erschienen am 28.10.2026. Verfasst von Ellen Stadler und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Antimicrobial Optimisation, Imperial College London, W12 0NN London, United Kingdom. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Imperial College London, University of Cambridge, Public Health England.
Abstract (Originalsprache)
Antimicrobial resistance is a growing global health threat. Overuse of antimicrobial drugs is a main driver of resistance, with urinary tract infections (UTIs) a common indication for antibiotic use. To improve UTI treatment and reduce antimicrobial resistance, real-time diagnostic tools for monitoring the host immune response are needed. Xanthine oxidase (XO) is an enzyme that is elevated in UTIs and shows potential for sensitive and selective detection of infection. We developed a rapid and sensitive point-of-care electrochemical sensor for XO detection by using a simple manufacturing approach. The sensor consists of a disposable carbon electrode embedded in a capillary fill chamber designed for point-of-care sample collection. After urine collection, XO catalyzes its substrate while changing the oxidation state of a secondary electron acceptor. The magnitude and rate of this redox shift reflects XO activity, enabling quantification of XO in urine. We demonstrate minimal intersensor variability of less than 5%, resulting in a calibration with an R2 of 0.985 across eight individual sensors. The capillary fill device was optimized to enable efficient substrate dissolution, reducing the time to result from 10 min to just 2 min. This approach enables calibration-free detection of XO in artificial and spiked human urine samples within 2 min of sample collection in both artificial urine and spiked human urine samples.
Autor:innen und Institutionen
- Centre for Antimicrobial Optimisation, Imperial College London, W12 0NN London, United Kingdom.
- Department of Infectious Diseases, Imperial College London, SW7 2AZ London, United Kingdom.
- National Institute for Health Research, Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, SW7 2AZ London, United Kingdom.
- Antimicrobial Discovery, Development and Diagnostics (AD3) UK Health Security Agency, Porton Down SP4 0JG, Salisbury, United Kingdom.
- Institute of Pharmaceutical Science, King's College London, London WC2R 2LS, United Kingdom.
- Healthcare Associated Infections, Fungal, Antimicrobial Resistance, Antimicrobial Use, and Sepsis Division, UK Health Security Agency, E14 4PU London, United Kingdom.
ORCID-Profile: Ellen Stadler, Danny O'Hare
Förderung
- Imperial College London
- University of Cambridge
- Public Health England
- University of Warwick
- National Institute for Health Research Health Protection Research Unit
Zitieren
APA
Stadler, E., Sutton, M., Brown, C., de Boer, W., Ammouri, R., Holmes, A., Rawson, T. M., & O'Hare, D. (2026). Rapid Point-of-Care Quantification of Urinary Tract Infection Biomarker Xanthine Oxidase. ACS Omega, 11(44), 69381-69388. https://doi.org/10.1021/acsomega.6c10153
Vancouver
Stadler E, Sutton M, Brown C, de Boer W, Ammouri R, Holmes A, et al. Rapid Point-of-Care Quantification of Urinary Tract Infection Biomarker Xanthine Oxidase. ACS Omega. 2026;11(44):69381-69388. doi:10.1021/acsomega.6c10153
BibTeX
@article{Stadler2026,
author = {Stadler, Ellen and Sutton, Mark and Brown, Colin and de Boer, Wubbo and Ammouri, Rahaf and Holmes, Alison and Rawson, Timothy M and O'Hare, Danny},
title = {Rapid Point-of-Care Quantification of Urinary Tract Infection Biomarker Xanthine Oxidase},
journal = {ACS Omega},
year = {2026},
volume = {11},
number = {44},
pages = {69381--69388},
doi = {10.1021/acsomega.6c10153}
}
EUVIMED